Compare Moderna, Inc. (MRNA) vs M&T Bank Corporation (MTB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs M&T Bank Corporation — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while M&T Bank Corporation trades at $248.99 (market cap $36.15B). The key difference: M&T Bank Corporation is the larger of the two by market cap, and M&T Bank Corporation pays a 2.41% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | MTB | |
|---|---|---|
Market Cap | $23.60B | $36.15B |
Sector | Health | Financials |
52-Week High | $81.80 | $254.04 |
52-Week Low | $22.36 | $178.63 |
Enterprise Value | $19.70B | — |
Dividend Yield | — | 2.41% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →
